CHAPLIN DAVID 4
4 · OXIGENE INC · Filed Sep 17, 2010
Insider Transaction Report
Form 4
OXIGENE INCOXGN
CHAPLIN DAVID
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2010-09-15+200,000→ 200,000 totalExercise: $0.28From: 2010-09-15Exp: 2020-09-15→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]The Stock Options vest as follows: (1) 25% vested on the grant date, and (2) the balance will vest in twenty-four equal installments beginning one month from the grant date.